Details for New Drug Application (NDA): 218711
✉ Email this page to a colleague
NDA 218711 describes BEIZRAY, which is a drug marketed by Zhuhai and is included in one NDA. It is available from one supplier. Additional details are available on the BEIZRAY profile page.
The generic ingredient in BEIZRAY is docetaxel. There are forty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the docetaxel profile page.
The generic ingredient in BEIZRAY is docetaxel. There are forty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the docetaxel profile page.
Suppliers and Packaging for NDA: 218711
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BEIZRAY | docetaxel | SOLUTION;INTRAVENOUS | 218711 | NDA | Zhuhai Beihai Biotech Co., Ltd. | 83513-010 | 83513-010-01 | 1 KIT in 1 CARTON (83513-010-01) * 4 mL in 1 VIAL, GLASS (83513-009-01) * 50 mL in 1 BOTTLE, GLASS (68982-643-01) * 4 mL in 1 VIAL, GLASS (83513-009-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 80MG/4ML (20MG/ML) | ||||
| Approval Date: | Oct 23, 2024 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
